Significant Revenue Growth
Evolent ended 2024 with revenue of $2.55 billion, reflecting a 30% growth compared to 2023.
New Contracts and Expansions
Evolent announced a technology and services contract with a large health plan in New England, covering 1.9 million new members, and a partnership with a primary care practice in the mid-Atlantic region for complex care services.
100% Logo Renewal Rate
Evolent achieved a 100% logo renewal rate for its top customers in 2024, representing more than 90% of its revenue.
Performance Suite Contract Renegotiations
Evolent secured $115 million in projected adjusted EBITDA improvement from renegotiating three Performance Suite contracts.
Investment in Automation and Efficiency
Evolent expects to achieve over $50 million in net value from automation and efficiency efforts, with a $20 million improvement anticipated by the end of 2025.